SkinCure Oncology’s GentleCure™ Experience to be Featured in National Public Health PSA Series
The PSA is being produced independently by World Impact Productions as part of the acclaimed “Breakthrough” TV PSA series.
- The PSA is being produced independently by World Impact Productions as part of the acclaimed “Breakthrough” TV PSA series.
- The educational public health series has been developed in collaboration with input from the National Center for Health Statistics, the National Institutes of Health and various think tanks and government agencies.
- The order, placed in fourth quarter 2023, provides for delivery of approximately 75 units from fourth quarter 2023 through third quarter 2024.
- The Company anticipates this will address its needs through ultimate finalization and clearance of its technology currently under development.